Dr Shannon Beattie
PhD cancer research, experience in developing PCR-based technologies. Leads operations and external engagement.
Professor Paul Mullan
Co-Founder and Professor of Oncology at QUB, with long-standing international recognition in cancer research, biomarker research and DNA methylation.
Dr Laura Feeney
Consultant medical oncologist, experienced in biomarker development with PhD in ovarian cancer biomarker identification.
Dr James Beirne
Consultant gynaecological surgical oncologist, significant academic and clinical experience, with PhD in ovarian cancer biomarker development.
Dr Mark Street Docherty
Seasoned IVD professional with experience in launching assays to market and exits.
Dr David Corr
Life sciences and deep-tech leader, experienced founder, has held senior leadership roles in R&D, IP and Investment Funds.
Dr Charlotte McBrien
Dr McBrien has a Masters in Biochemistry, and a PhD in molecular cancer research.
Charlotte is the lead scientist in the ovarian cancer research programme. She has extensive experience in handling and analysing large datasets as well as molecular biology techniques.
Charity Hall
Charity has a Master’s in Science. She has several years of industry experience before joining GenoME in 2023.
Charity is the lead scientist in the pancreatic research programme. She has extensive experience in handling and analysing large datasets, NGS as well as molecular biology techniques.
Mr Jim Thurlow
A seasoned diagnostics and biotech leader with deep R&D, quality and industry expertise.